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Abstract Tenascin-X (TNX) is a large, multi-domain, 
extracellular matrix glycoprotein. Complete deficiency of 
TNX in humans leads to a recessive form of Ehlers-Danlos 
syndrome (EDS), and TNX haploinsufficiency is a cause of 
hypermobility type EDS. EDS patients appear to have a 
higher risk of several complications during pregnancy, such 
as pelvic instability, premature rupture of membranes, and 
postpartum hemorrhage. Here, we present a study of
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genitourinary and obstetric complications in TNX-deficient 
women of reproductive age. We have found complications, 
such as uterus prolapses, that are in agreement with 
previous findings in other EDS types. In TNX knockout 
(KO) mice, we have observed mild pregnancy-related 
abnormalities. Morphological and immunohistological anal­
ysis of uterine tissues has not revealed obvious quantitative 
or spatial differences between TNX KO and wildtype mice 
with respect to collagen types I, III, V, and XII or elastic 
fibers. We conclude that TNX-deficient women are at risk 
of obstetric complications, but that TNX KO mice show 
only a mild phenotype. Furthermore, we show that TNX is 
involved in the stability of elastic fibers rather than in their 
initial deposition.
Keywords Ehlers-Danlos syndrome . Tenascin-X .
Collagen. Elastin. Pregnancy. Human ■
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Introduction
Tenascin-X (TNX) is a large, multi-domain, extracellular 
matrix (ECM) glycoprotein composed of epidermal growth 
factor (EGF) like-repeats, fibronectin type III repeats, and a 
C-terminal fibrinogen domain (Bristow et al. 1993; Lethias 
et al. 1996; Elefteriou et al. 1997; Ikuta et al. 1998; Tucker 
et al. 2006). Complete deficiency of TNX in humans leads 
to a rare recessive form of Ehlers-Danlos Syndrome (EDS), 
and TNX haploinsufficiency is a cause of hypermobility 
type EDS. Patients of both EDS types exhibit mild to 
severe joint hypermobility. The skin of TNX-deficient 
patients is markedly lax with poor recoil properties and 
shows easy bruising. The collagen density appears reduced 
in the dermis of these patients, and the elastic fibers are
Ô  Springer
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abnormal (Burch et al. 1997; Schalkwijk et al. 2001; 
Zweers et al. 2003; Peeters et al. 2004; Lindor and Bristow
2005). Most of the literature concerning pregnancy in EDS 
uses the old classification of nine subgroups. In our study, 
we use the revised classification of six subtypes of EDS 
(Beighton et al. 1998). Tissue fragility is a hallmark of EDS 
and is present in all the different subtypes. EDS patients 
appear to have a higher risk of several complications during 
pregnancy, such as pelvic instability, premature rupture of 
membranes, and postpartum hemorrhage. Pregnancy in 
classical and hypermobility type EDS has a relative 
favorable maternal and neonatal outcome. Pregnancy in 
vascular type EDS patients is associated with severe 
complications including maternal mortality (Pepin et al. 
2000; Carley and Schaffer 2000; Roop and Brost 1999; 
Wegrowski et al. 1999; Ramos-e-Silva et al. 2006; Lind and 
Wallenburg 2002; Kuczkowski 2005; Parry and Strauss 
1998). The effect of TNX deficiency on pregnancy has not 
been studied so far, and only one case report of pregnancy 
in a TNX-deficient woman has been reported in the 
literature (Lindor and Bristow 2005). Here, we present a 
study of all known pregnancies and genito-urinary (GU) 
abnormalities in TNX-deficient woman of reproductive age 
identified in our clinic (Schalkwijk et al. 2001) and in the 
literature (Lindor and Bristow 2005; Schalkwijk et al. 
2001). Furthermore, we have extended our studies to a 
TNX knockout (KO) mouse model in which we have 
investigated uterine development during pregnancy. We 
have previously established that TNX is essential for the 
development of tissue strength in the skin and is able to 
bind to elastin, a major component of elastic fibers, and to 
collagens type I, III, V, and XII (Egging et al. 2006a, b ; Veit 
et al. 2006). We have investigated the expression of these 
molecules at the protein level.
Materials and methods
TNX-deficient patients
We investigated pregnancies and GU abnormalities in all 
currently identified female tenascin-X deficient patients of 
reproductive age identified in our clinic and in the 
literature. The study protocol was approved by the local 
medical ethics committee, and written informed consent 
was obtained from the patients.
Experimental animals
TNX knockout (KO) mice were obtained as described 
previously (Mao et al. 2002). For all studies, we used TNX 
KO mice that were crossed back with six generations of 
C57BL/6N mice. Wildtype C57BL/6 (WT) mice were used
as a control. All mice investigated for pregnancy abnor­
malities and morphological changes in uterus tissue were 
between 2 and 6 months of age, reflecting a normal age 
distribution of a breeding mice population. Skin samples 
were taken from 2-month-old and 9-month-old mice, and 
aortic tissue was obtained from 9-month-old mice. The 
experimental design was approved by the Animal Use 
Committee of Radboud University, Nijmegen.
Breeding
Breeding pairs were kept in a 5:1 female:male ratio. Females 
were inspected daily for vaginal plugs, and those with plugs 
were isolated and inspected each day for abnormalities and 
progression of pregnancy. Litter size was determined after 
birth. Neonatal survival is defined as the difference in litter 
size after partus and 2 weeks postpartum.
Processing of samples for (immuno)histochemistry
Mice were killed in a sealed compartment by exposure to a 
mixture of carbogen gas and increasing concentrations of 
CO2. Skin samples for frozen sections were embedded in 
Tissue-Tek O.C.T. compound (Sakura Finetek Europe, The 
Netherlands) and snap frozen in liquid nitrogen. Skin 
samples for paraffin sections were fixed in 4% buffered 
formalin for 4 h.
Affinity-purified TNX antibody production
TNX FNIII repeats 27-32 were amplified by polymerase 
chain reaction (PCR; forward primer: 5’-GGAATTCGAGC 
TACCTCCCCAC-3’, reverse primer: 5’-CAGGTCGACT 
CAGGTGAAAGAGGTGGA-3’) by using a previously 
described 2.7-kb human TNX cDNA as a template (Morel 
et al. 1989). The PCR product was ligated into the 
pCR2.1TOPO vector (Invitrogen, Breda, The Netherlands) 
according to the manufacturer’s instructions for easy 
digestion with restriction enzymes. The pCR2.1 TOPO 
vector with insert was digested with EcoRI and SalI. The 
region coding for FNIII27-32 was inserted into the EcoRI/ 
SalI site of the pET28(a)+ plasmid (Brunschwig Chemie, 
Amsterdam, The Netherlands). The sequence of the TNX 
domains was verified by dideoxy sequencing with a 3730 
DNA analyzer (Applied Biosystems, Nieuwekerk a/d IJssel, 
The Netherlands). TNX FNIII27-32 protein was expressed 
and purified according to the manufacturer’s instructions 
(Brunschwig Chemie). Purified TNX FNIII27-32 protein 
was used for immunization of a rabbit. Aliquots of 500 |o.g 
TNX FNIII27-32 in 500 |o.l phosphate-buffered saline were 
mixed with an equal volume of Freund’s complete adjuvant 
for the first injection and Freund’s incomplete adjuvant for 
boosters. Three injections were administered subcutaneously
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Table 1 Pregnancy in TNX-deficient woman (VUE  vaginal uterine extirpation, 1UD intra-uterine death, CAH congenital adrenal hyperplasia). 
Age represents the age o f the patient at the anamnesis
Patient ID Age Gravida number/ Genito-urinary complications
(years) Para number
Specification
1 50
2 (sister o f  60 
patient 1)
3 46
4 (sister o f  51 
patient 3)
5 38
6 51
57*
G1P1
G2P2
G0P0
G3P3
G0P0
G3P2
G4P4
None
VUE after uterine prolapse (at age 49)
Vaginal prolapse 2 weeks after VUE 
None
One incident o f hemorrhage postpartum 
(>1000 ml blood loss)
None
IUD (24 weeks) with relatively large 
blood loss
Undefined prolapse (at age 36)
Precipitious second stage at term for all births 
Uterine prolapse (at age 20), also recurrent 
rectal prolapses
None
None
None
Was born prematurely (week 35) with 
shoulder luxation, rectal prolapse at age 1
None
CAH
Deceased at age 51, severe co-morbidity 
including cardiomyopathy, arrhythmia, 
arteriosclerosis, and amputation o f left leg 
(Schalkwijk et al. 2001).
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at 3-week intervals. Polyclonal antibodies against TNX 
FNIII27-32 were purified by affinity chromatography on a 
column with the antigen coupled to CNBr-activated sephar- 
ose 4B (GE Healthcare Life Sciences, Diegem, Belgium).
Histopathology, histochemistry, and immunohistochemistry
Staining of elastic fibers was performed by modified Hart’s 
stain on paraffin sections (7 |o.m; Starcher et al. 2005). 
Paraffin sections were also stained with hematoxylin and 
eosin (H&E) stain to assess uterus morphology and 
pathology, in collaboration with a professional pathologist. 
Frozen sections (7 |o.m) were stained with antibodies against 
collagen types I, III, and V (SouthernBiotech, USA) and 
elastin (Elastin Products, USA) as previously described by 
Egging et al. (2006b). Collagen XII was stained as 
previously described by Veit et al. (2006). TNX was stained 
with affinity-purified antibodies directed against FNIII27-32 
of TNX. Detection was performed with antibodies labeled 
with fluorescein isothiocyanate (FITC, green; DakoCytoma- 
tion, Denmark) and Alexa Fluor 594 (AF594, red; Molecular 
Probes, The Netherlands). Cell nuclei were made visible with 
4,6-diamidino-2-phenylindole (DAPI, blue; Molecular 
Probes) counterstaining. Assesment of immunostaining was 
performed as previously described (Egging et al. 2007, 
2006b). Images were captured and processed with Axiovi- 
sion software (Carl Zeiss, The Netherlands).
Electron microscopy
For electron microscopy, WT and TNX KO samples from 
uterine wall at 3 weeks post-partum, skin from 2-month-old 
and 9-month-old mice, and aortas from 9-month-old mice
were fixed in 3% glutaraldehyde in 0.1 M sodium 
cacodylate overnight and washed in 0.1 M sodium 
cacodylate buffer. The tissues were then sequentially treated 
with osmium tetroxide, tannic acid, and uranyl acetate and 
then dehydrated and embedded in Epon as previously 
described (Davis 1993). Thin sections (60 nm) were 
counterstained with 7% uranyl acetate in absolute methanol 
and lead citrate and examined in a Tecnai 12 transmission 
electron microscope, at 120 kV.
Statistics
For statistical analyses, Fisher’s exact or Chi-square tests 
were used where appropriate for proportional data. Stu­
dent’s t-test was used to compare mean litter size after 
partus and neonatal survival (difference in litter size after 
partus and 2 weeks postpartum). A P-value of <0.05 was 
considered statistically significant.
Table 2 Pregnancy in TNX-deficient mice
Genito-urinary complications TNX KO mice 
Number o f  mice
WT mice 
Number o f mice
Maternal death during 1 0
pregnancy
Miscarriage 2 0
Obstruction during partus 1 3
Excessive bleeding o f vagina 2 0
(as seen at vaginal plug
check)
Cannibalism after partus 1 1
Total number o f  evaluated 36 31
pregnancies
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TNX KO WT
Fig. 1 TNX KO mice abnormalities. Vaginal plugs, which are present 
after mating, are much more difficult to asses in TNX KO mice than in 
WT mice. This resulted in a significant increase o f pregnancies in 
which the date o f impregnation was unknown (a, *P<0.025, Chi- 
square test). Total evaluations: TNX KO mice, n=32; WT mice, n=28. 
In this study, no uterine prolapses were observed, although some TNX 
KO mice suffered from a rectal prolapse (b). Rectal prolapses were 
also observed in TNX-deficient patients, although the incidence in 
TNX KO mouse was lower (<1% in mice)
Results
Pregnancy in TNX-deficient patients
We investigated pregnancy and GU abnormalities in TNX- 
deficient woman of reproductive age. General reproduction 
characteristics and GU abnormalities of female TNX- 
deficient patients are presented in Table 1. Maternal and 
neonatal outcome was generally normal; one out of 13 
pregnancies resulted in an intrauterine death of the fetus. 
Tissue laxity of TNX-deficient patients was demonstrated 
by the occurrence of vaginal, uterine, and rectal prolapses, 
even at a relative young age. One case of postpartum 
hemorrhage was observed in 12 childbirths. None of our 
patients had urinary incontinence symptoms. TNX-deficient 
EDS is an autosomal recessive disorder; therefore, all 
offspring of a TNX-deficient patient and an unaffected 
individual are obligatory heterozygotes. We have previous­
ly found that approximately 60% of adult females that are 
haploinsufficient for TNX suffer from hypermobility type 
EDS or benign joint hypermobility syndrome (Zweers et al. 
2003). We found no obvious abnormalities (e.g. floppy 
infant syndrome, premature birth) in the neonates (obliga­
tory heterozygotes) of our TNX-deficient population; 
however, some TNX-deficient patients themselves were 
born prematurely (Table 1 ; Lindor and Bristow 2005). Four 
out of six of the TNX-deficient women had postpartum 
complications (one of the patients had no pregnancies). 
This was in agreement with the findings in the literature of 
an increase in maternal GU complications in EDS-deficient 
women compared with the control population (Ainsworth 
and Aulicino 1993; Carley and Schaffer 2000; Kuczkowski 
2005; Lind and Wallenburg 2002; Ramos-e-Silva et al.
2006).
Pregnancy in TNX KO mice
We investigated GU and pregnancy-related abnormalities in 
TNX KO and WT mice ranging between 2-6 months of 
age. Litter size (TNX KO: 7±2 pups, WT: 7±3 pups) and 
neonatal survival (TNX KO: 74%±36%, WT: 54%±40%) 
did not differ significantly (Student’s t-test). GU abnormal­
ities of the TNX KO and WT mice are presented in Table 2. 
Overall, we noted relatively few pregnancy-related abnor­
malities. Obstruction of the uterine or vaginal canals during 
partus resulting in a failure to deliver pups was noted more 
often in WT mice compared with TNX KO mice, but the 
difference was not significant (Chi-square test). The length 
of term did not differ significantly for the TNX KO mice 
(mean: 19.3 days) compared with WT mice (mean: 
19.6 days, Fisher’s exact test). A striking difference, 
however, between TNX KO and WT was found for the 
location of the vaginal plug that was present after mating. 
Generally, the vaginal plug in TNX KO mice was located 
much deeper in the vaginal canal than in WT mice. This 
made identification of vaginal plugs in TNX KO mice 
markedly more difficult, resulting in a significant increase 
in pregnancies with unknown length of pregnancy (Fig. 1a, 
Chi-square test). No uterine or rectal prolapses were 
observed in this particular study (67 pregnancies of KO 
and WT mice). We did, however, observe rectal prolapses 
in the breeding colony of our TNX KO mice population 
(shown in Fig. 1b), albeit at a low frequency (<1%). We did 
not observe rectal prolapses in our WT mice population.
Structure of mouse uterus
The mouse uterus consists of three layers: an outer layer, 
which includes the single-cell layered perimetrium and a 
thin layer of connective tissue; a muscular layer, the 
myometrium, composed of two oppositely orientated layers 
of muscle; and an endometrium, which undergoes remodel­
ing during the menstrual cycle and pregnancy. The
Wild type mouse TNX KO mouse
Fig. 2 Structure o f TNX KO and W T uterus. H&E-stained sections of 
the uterus o f WT mice (a) and o f TNX KO mice (b). No differences in 
the structure o f the uteri were noticeable between TNX KO and WT 
mice. The mouse uterus consists o f a thin outer layer, the perimetrium 
(P). A muscle layer, the myometrium (M), consists o f  two oppositely 
orientated layers o f muscle, although this is difficult to distinguish in 
H&E-stained slides (E endometrium, L lumen). Bars 0.01 mm
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endometrium contains luminal and glandular epithelial 
cells, stromal cells, resident immune cells of various types, 
and endothelial cells. No differences in the overall 
morphology of the uterine tissues were noticeable between 
TNX KO and WT mice (Fig. 2; uteri on 1 day postpartum) 
as assessed by light microscopy of H&E-stained sections. 
As we mainly focused on the ECM compartment of the 
uterus, we did not attempt to make quantitative analyses of 
the cell type distribution.
TNX distribution in mouse uterus
TNX was present throughout the uterus of virgin mice and 
in the uterus during and after pregnancy (Fig. 3a-c). 
Immunostaining for TNX was discontinuous in the peri­
metrium (Fig. 3a-c,f). TNX was detected in the endometri­
um, although the epithelium lining the endometrium was 
negative for TNX (Fig. 3d). Furthermore, TNX was present 
in the layers of connective tissue ensheathing the muscle 
bundles of the myometrium (Fig. 3f). Overall, no change in
the localization of TNX immunostaining was observed 
during and after pregnancy. The specificity of our TNX 
antibody was demonstrated by the complete absence of 
positive staining in the tissues of the TNX KO mice 
(Fig. 3e,g).
Collagen distribution in mouse uterus
We have previously demonstrated the binding and the 
colocalization of TNX with collagen types I, II and V, in the 
skin (Egging et al. 2006a, b). In the uterus, TNX also 
colocalizes with major fibrillar collagens types I, III, and V, 
as is shown for uteri 3 weeks postpartum (Fig. 4). The 
collagens are present in the perimetrium, the endometrium, 
and the layers of the connective tissue ensheathing the 
muscle bundles of the myometrium. Similar results have 
been obtained for uteri from virgin, 13-days pregnant, and 
1-day postpartum mice. No differences in collagen type I,
III, and V immunostaining are found between WT and TNX 
KO mice (data not shown), which is in agreement with our
Fig. 3 Immunostaining o f TNX 
in the uterus (P perimetrium, M  
myometrium showing longitudi­
nal muscle bundles, M* myo­
metrium showing transverse 
muscle bundles, E  endometrium, 
Epi epithelium of the lumen, L 
lumen). TNX (green) is present 
throughout the uterus o f virgin 
mice (a) and in the uterus during 
and after pregnancy, shown for 
uteri at 13 days pregnant (b) and 
3 weeks postpartum (c). Cell 
nuclei are stained with DAPI 
(blue). TNX is present in the 
endometrium (d) and the layers 
of connective tissue ensheathing 
muscle bundles o f the myome­
trium (f). TNX immunostaining 
of the perimetrium is relatively 
weak (a-c, f). The epithelium of 
the lumen is negative for TNX 
(d). The specificity o f the TNX 
antibody is demonstrated in e, g. 
d -g  Uteri at 3 weeks postpar­
tum. Bars 50 ^.m
Virgin 13 days pregnant 3 weeks post partum
,-D 0) P b C «- P
M i
M
M
M*
M*
E M*
_  E _  E
Wild type mouse TNX KO mouse
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type I
d
type III
g
type V
Fig. 4 TNX colocalizes with major fibrillar collagens types I, III, and 
V (P perimetrium, M  myometrium with longitudinal muscle bundles, 
M* myometrium with transverse muscle bundles, E  endometrium, Epi 
epithelium o f the lumen, L lumen). TNX (b, e, h, green) and collagen 
types I (a), III (d), and V (g, red) colocalize (c, f, i, yellow, orange, 
magenta) in uteri 3 weeks postpartum. Similar results have been
obtained for uteri from virgin, 13-days pregnant, and 1-day postpar­
tum mice. No differences in collagen type I, III, and V immunostain- 
ing are apparent between WT and TNX KO mice (data not shown). In 
k, l, m, higher magnification images o f  the myometrium are shown to 
demonstrate the colocalization o f the fibrillar collagens with TNX 
(collagen type III is used as an example). Bars 50 ^.m
observations in skin (Egging et al. 2006b). TNX does not 
exclusively colocalize with collagens, however, because 
TNX also cololalizes with other ECM components such as 
(tropo)elastin. Collagen type XII, an interaction partner of 
TNX (Veit et al. 2006), is present throughout the uterus 
(Fig. 5). Collagen type XII occurs in the transverse muscle 
bundles of the myometrium around blood vessels and 
around the lumen, although the signal intensity is not 
completely continuous around the lumen and blood vessels.
TNX and collagen type XII are both present throughout the 
uterus. No differences in the collagen type XII localization 
in the uterus between WT (Fig. 5a,c,e,g) and TNX KO 
(Fig. 5b,d,f,h) mice have been observed.
Elastic fibers in mouse tissues
Elastic fibers in the skin of TNX-deficient patients are 
known to be abnormally shaped (Zweers et al. 2004), and
Springer
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Fig. 5 Immunostaining of collagen type XII in uterus (P perimetrium, 
M  myometrium with longitudinal muscle bundles, E  endometrium). 
Collagen XII (red) is present throughout the uterus. Immunostaining 
appears to be the strongest in the transverse muscle bundles o f the 
myometrium (M*), around blood vessels (BV), and around the lumen 
(L ), although the signal intensity is not always completely continuous. 
No differences in the collagen type XII localization in the uterus 
between WT (a, c, e, g) and TNX KO (b, d, f, h) mice are observed. 
Bars 50 ^.m
thus we have investigated their structure in TNX KO mouse 
tissues. Elastic fibers in the uterus are mostly located in the 
myometrium and perimetrium (Fig. 6a,b). The endometri­
um contains few elastic fibers as shown for WT (Fig. 6a) 
and TNX KO (Fig. 6b) mice. In the myometrium and 
perimetrium, positive staining for elastin is seen predomi­
nantly in the layers of connective tissue ensheathing the 
transverse muscle bundles (Fig. 6c,d). Despite the relative 
low abundance of mature elastic fibers in the endometrium, 
the presence of elastin can be detected by immunohisto- 
chemistry, possibly a consequence of the sensitivity of the 
detection methods (Fig. 6c-d). Elastin localization is similar 
for WT (Fig. 6c) and TNX KO (Fig. 6d) mice. We have 
previously demonstrated binding of TNX with elastin and 
the colocalization of these two proteins in skin (Egging 
et al. 2006a, b). Consistent with these findings, elastin also
(partially) colocalizes with TNX in the uterus, as shown in 
the myometrium (Fig. 6e). Colocalization of TNX with 
elastin is not complete, since TNX also colocalizes with 
fibrillar collagens; however, all elastin-reactive material 
colocalizes with TNX. In previous work, we have showed 
an increase in elastin-positive material in the skin of aging 
TNX KO mice (Egging et al. 2006a, b). Although, by light 
microscopy, the elastic fibers in the TNX KO mouse skin 
do not appear to be abnormally shaped, an increase in 
staining might have resulted from an increase in less mature 
or less organized elastin fibers, an increase in soluble 
tropoelastin within the matrix, and/or the consequence of 
more immunoreactive epitopes being available because of 
an increased susceptibility for degradation. These results 
are consistent with our past observations of elastic fibers in 
the skin of TNX-deficient patients in whom irregular and 
immature elastic fibers and fibers devoid of microfibrils can 
be seen at the ultrastructural level (Egging et al. 2006b; 
Zweers et al. 2004). Thus, to expand these findings further 
in skin and to investigate the elastic fibers in the uterus, we 
have performed an ultrastructural analysis of the elastic 
fibers in several tissues. Elastic fibers in WT (Fig. 7a) and 
TNX KO mice (Fig. 7b) uteri do not appear to differ in 
shape or size (shown for uterus 3 weeks postpartum). 
Similarly, in aorta, the elastic laminae of WT (Fig. 7c) and 
TNX KO mice (Fig. 7d) are similar in shape and number 
(aorta of 9-month-old mice). In skin of older TNX KO mice 
(as shown for 9-month-old mice), however, a difference in 
elastic fiber ultrastructure is apparent compared with WT skin. 
In addition to normal-appearing elastic fibers, irregular elastin 
aggregates, as seen in the skin of TNX-deficient patients 
(Zweers et al. 2004), can be observed (Fig. 7e,f). These 
elastin aggregates are not found in the skin of 2-month-old 
TNX KO mice or in 9-month-old WT mice. Interestingly, 
elastic fibers in the skin of 9-month-old TNX KO mice often 
appear larger than those of WT mice of the same age 
(compare Fig. 7g,h).
Discussion
GU complications occur frequently in patients with various 
types of EDS (Carley and Schaffer 2000; Ramos-e-Silva 
et al. 2006; Lind and Wallenburg 2002; Kuczkowski 2005; 
Parry and Strauss 1998; Pepin et al. 2000). In classical and 
hypermobility types of EDS, which are the most common, 
the outcome of pregnancy is generally favorable. Maternal 
complications however, such as postpartum hemorrhage 
and pelvic instability, are more common than in the general 
population (Ramos-e-Silva et al. 2006; Kuczkowski 2005; 
Parry and Strauss 1998). Furthermore, EDS patients appear 
to have an elevated risk of uterine prolapse (Carley and 
Schaffer 2000; Lind and Wallenburg 2002). Pregnancy in
Ô  Springer
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Fig. 6 Elastin and elastic fibers in the uterus (L lumen). Elastic fibers 
(purple, modified Hart’s staining) are mostly located in the myome­
trium (M , M *) and perimetrium (P), whereas the endometrium (E) 
appears to contain fewer elastic fibers in WT (a) and TNX KO (b) 
mice. No elastic fiber abnormalities are found in the TNX KO mice. 
Elastin immunostaining (red) is observed in the myometrium, 
predominantly in the transverse bundles (M* in c, d). The layers o f
connective tissue ensheathing the muscle bundles o f the myometrium 
(M) and perimetrium (P) are stained positively for elastin (red). Strong 
elastin staining is also seen in the endometrium (E). Elastin 
immunoreactivity is similar for WT (c) and TNX KO (d) mice. 
Elastin (red) colocalizes (orange) with TNX (green) in the myome­
trium (M* in e). Not all TNX colocalizes with elastin as TNX also 
colocalizes with different collagen types (Fig. 4). Bars 50
patients with vascular type EDS may even lead to maternal 
death through uterus or vessel rupture (Pepin et al. 2000). 
We have investigated pregnancies and GU abnormalities in 
TNX-deficient woman of reproductive age. Generally, 
pregnancy is without major complications in TNX-deficient 
patients, apart from one noted incident of postpartum 
hemorrhage. However, uterine and vaginal prolapse regu­
larly occur in TNX-deficient women, even at a young age, 
suggesting laxity of GU tissues. Premature rupture of fetal 
membranes is a risk in pregnancy with EDS affected fetuses 
(Lind and Wallenburg 2002; Parry and Strauss 1998). No 
premature births have been observed in the offspring of the 
TNX-deficient patients; however, some TNX-deficient 
patients had been born prematurely. Obviously, some 
caution must be taken in making conclusions and extrap­
olating data from such a small group of TNX-deficient 
woman.
Complete TNX deficiency in humans is a rare condition, 
and so far, only a few patients have been identified. We 
have therefore investigated pregnancy and uterine tissue 
structure in our TNX KO mouse model. No gross 
significant differences have been found with regard to 
abnormalities during pregnancy or reproduction between 
the TNX KO and WT mice. A trend toward a reduction in 
the length of pregnancy in TNX KO mice. The only
significant difference has been observed in the location of 
the vaginal plugs, which suggests laxity in the vaginal wall.
In a previous study, we have not found any differences in 
cutaneous collagen deposition between TNX KO and WT 
mice (Egging et al. 2006b), as has been observed in the skin 
of TNX-deficient patients (Schalkwijk et al. 2001; Zweers 
et al. 2004). Alterations in collagen deposition in the skin of 
TNX KO mice is, however, a matter of debate (Egging 
et al. 2006b; Mao et al. 2002; Minamitani et al. 2004). In 
the present study, we have found elastin aggregates and 
enlarged elastic fibers in 9-month-old skin of TNX KO 
mice at the ultrastructural level; this is in accordance with 
our previously published data concerning increased elastin 
staining in aging TNX KO mouse skin (Egging et al. 
2006b). We have detected no differences in elastic fibers in 
the uterus or elastic laminae of the abdominal aorta between 
TNX KO and WT mice suggesting a specific role for TNX 
in the maturation or maintenance of elastic fibers in skin. 
However, abnormal elastic fibers might not be present in 
the uterus, since the ECM is constantly being remodeled 
during the menstrual cycle and pregnancy.
Although the TNX KO mice appear to have a much 
milder phenotype compared with TNX-deficient humans, 
the skin of TNX KO mice is significantly weaker and more 
lax compared with WT mice (Bristow et al. 2005; Burch
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Cell Tissue Res (2008) 332:523-532 531
Fig. 7 Ultrastructural evalua­
tion of elastic fibers. Elastic 
fibers in WT (a) and TNX KO 
(b) mouse uterus do not appear 
to differ in shape or size. The 
dark structures (arrows) are 
elastic fibers (shown for uterus 
at 3 weeks postpartum). The 
elastic laminae (arrows) in the 
aorta o f W T (c) and TNX KO 
(d) mice are similar in shape and 
number (aorta o f 9-month-old 
mice). Skin o f older TNX KO 
mice (9 months old) shows 
differences in elastic fibers from 
those o f WT skin. Irregular 
elastin aggregates can be ob­
served in the TNX KO mouse 
skin (e, near a sebaceous gland). 
A higher magnification o f an 
elastin aggregate (arrow) is 
shown in f. These aggregates 
were not found in skin o f 2- 
month-old TNX KO mice or in 
9-month-old WT mice. No ir­
regularities in the shape of 
elastic fibers are observed in 9- 
month-old TNX KO mice skin; 
however, larger elastic fibers 
than in WT mice (g) are often 
observed in the TNX KO mice 
(h, arrows elastic fibers). Bars 
0.5 ^.m (a, b), 10 ^.m (c, d),
2 ^.m (e, g, h), 1 ^.m (f)
et al. 1997; Egging et al. 2006b; Lindor and Bristow 2005; 
Mao et al. 2002; Matsumoto et al. 2001; Minamitani et al. 
2004; Schalkwijk et al. 2001; Zweers et al. 2004). Our data 
suggest a more lax vaginal canal in TNX-deficient patients 
and to a certain degree in TNX KO mice. An attractive 
speculation, considering the observations from our studies
in mice, is that TNX is essential for tissue integrity, 
independent of the quantity of collagen deposition or elastic 
fiber structure. In conclusion, we would advise obstetricians 
and gynecologists to monitor TNX-deficient patients 
closely, as they are likely to have weaker GU connective 
tissue and could therefore be at risk of GU complications.
Ô  Springer
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